Janssen’s HIV drug SYMTUZA yields positive results in DIAMOND trial

This article was originally published here

The trial, called DIAMOND, is the first prospective phase 3 trial which is assessing the rapid initiation of a single-tablet regimen (STR) SYMTUZA for the treatment of human

The post Janssen’s HIV drug SYMTUZA yields positive results in DIAMOND trial appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply